Please assess the completion status of the following clinical trial:

Trial Title: A Study of Exercise Endurance and Lung Hyperinflation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* A diagnosis of stable moderate to severe COPD (GOLD 2006); post-levalbuterol FEV1 \>=30% and \< 80% predicted and FEV1/FVC\<70% predicted~* Current or former cigarette smoker~* Functional Residual Capacity (FRC) measured by body plethysmography \>= 120% of predicted value~* Baseline Dyspnea Index (BDI) focal score ≤ 7 at Visit 4~Exclusion Criteria:~* History of presence of asthma, allergic rhinitis, or atopy~* Hospitalization for acute COPD exacerbation in the 3 months prior to study entry~* Respiratory tract infection (including the upper respiratory tract) or COPD exacerbation in the 6 weeks prior to study entry~* Clinically significant respiratory conditions other than COPD~* Chronic use of oxygen therapy \>= 15 hours a day

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Aclidinium (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).